- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06354309
The Impact of Immersive Virtual Reality Training on Adult: Motion Sickness, and Ocular Surface: A Pilot Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
- Title: The Impact of Immersive Virtual Reality Training on Adult: Motion Sickness, and Ocular Surface: A Pilot Study.
- Purpose: To evaluate the initial safety impact of head-mounted virtual reality (HMVR) devices with virtual reality amblyopia training games on postural stability, motion sickness, and ocular surface in healthy adult participants.
- Methods: A total of 38 healthy adult volunteers (18 males, 20 females) aged 18-42 years old were recruited from Shenyang He Eye Specialist Hospital from July to August 2023. Inclusion criteria: age ≥18 years; BCVA >=1.0; Titmus is between 40-60 ". Exclusion criteria: history of eye surgery and trauma within 3 months; Active eye problems; Pregnancy or lactation; Those who were determined by the investigator to be unsuitable for this study. This study was approved by the Ethics Committee of Shenyang He Eye Specialist Hospital (IRB(2023)K023.01).
3.1Research equipment Pico VR all-in-one (Neo2 Lite, Hainan Creative Vision Future Technology Co., LTD., China (referred to as "PICO") is a VR headset, which is used together with BeiShiYou visual function training software (BV-2, Shenyang BeiYou Technology Co., LTD., referred to as "BeiShiYou") 3.2 Procedure The procedure was divided into four steps: A. Sign the informed consent. B. First ophthalmic examination (diopter, BCVA, ocular position, stereo vision, postural stability, non-invasive tear breakup time, tear meniscus height, red eye analysis, lipid layer classification, eye blink frequency, eye surface temperature) and questionnaires survey (simulator sickness questionnaire, semans balance disorder scale, ocular surface disease index dry eye questionnaire, visual quality questionnaire and visual fatigue questionnaire). C. Conduct the first VR headset game training for 30 minutes, and then conduct the second eye examination and questionnaire survey above. D. Conduct the second VR headset game training for 30 minutes, and then conduct the third eye examination and questionnaire survey above (Figure 2).
3.3 Observation Indicators includes Simulator sickness questionnaire (SSQ), Postural stability, Non-invasive tear breakup time (NITBUT), Tear meniscus height, Lipid layer classification, Eye blink frequency, Central ocular surface temperature, Dry eye questionnaire score, Visual quality questionnaire score, Visual fatigue score.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Liaoning
-
Shenyang, Liaoning, China, 110034
- He Eye Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age >= 18
- Best vision >=1.0
- Titmus is between 40s and 60s
Exclusion Criteria:
- History of eye surgery and trauma within 3 months
- Active eye diseases
- Pregnancy and lactation period
- Allergic to fluorescein sodium
- The researcher determined that the subjects were not suitable for this study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Pre and post control study
The subjects used the HMVR for 2 sessions of game training (30 minutes each, 10 minutes intervals).
|
Pre and post control study after use virtual reality game
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Simulator Sickness Questionnaire Score
Time Frame: Baseline, 30min, 60min
|
Record the simulator sickness questionnaire score after use virtual reality game
|
Baseline, 30min, 60min
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Postural stability
Time Frame: Baseline, 30min, 60min
|
Record the postural stability level after use virtual reality game
|
Baseline, 30min, 60min
|
Non-invasive tear breakup time
Time Frame: Baseline, 30min, 60min
|
Check with Eye Surface Analyzer (OCULUS, Germany)
|
Baseline, 30min, 60min
|
Tear meniscus height
Time Frame: Baseline, 30min, 60min
|
Check with Eye Surface Analyzer (OCULUS, Germany)
|
Baseline, 30min, 60min
|
Lipid layer classification
Time Frame: Baseline, 30min, 60min
|
Check with DR-1 dry eye measurement
|
Baseline, 30min, 60min
|
Eye blink frequency
Time Frame: Baseline, 30min, 60min
|
Collect the blink frequency with DJI Pocket 2 Creator Combo (Shenzhen DJI Innovation Technology Co., LTD.)
|
Baseline, 30min, 60min
|
Eye surface temperature
Time Frame: Baseline, 30min, 60min
|
Collect eye surface temperature with Flir ONE Pro mobile phone Infrared thermal camera for Apple IOS (Teledyne FLIR, USA)
|
Baseline, 30min, 60min
|
Ocular surface disease index dry eye questionnaire score
Time Frame: Baseline, 30min, 60min
|
Record with OSDI questionaire
|
Baseline, 30min, 60min
|
Visual quality questionnaire score
Time Frame: Baseline, 30min, 60min
|
Record with visual quality questionnaire
|
Baseline, 30min, 60min
|
Visual fatigue questionnaire score
Time Frame: Baseline, 30min, 60min
|
Record with visual fatigue questionaire
|
Baseline, 30min, 60min
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ling Xu, MD, He Eye Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- vr_study
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dry Eye
-
Gordon Schanzlin New VisionCompletedDry Eye | Dry Eye Disease | Evaporative Dry Eye | Kerato Conjunctivitis Sicca | Evaporative Dry Eye Disease | Dry Eye, EvaporativeUnited States
-
Kao (Taiwan) CorporationChang Gung Memorial HospitalCompletedEye Fatigue | Dry Eye SymptomTaiwan
-
Alcon ResearchCompletedVisual Performance | Dry Eye Symptoms
-
Alcon ResearchCompletedModerate to Severe Dry Eye
-
Singapore National Eye CentreCompleted
-
AllerganCompletedDry Eye Syndrome | Dry Eye DiseaseUnited States
-
Senju Pharmaceutical Co., Ltd.CompletedDry Eye Syndrome | Dry Eye DiseaseUnited States
-
Bausch & Lomb IncorporatedCompletedDry Eye Disease (DED)United States
-
Centre for Contact Lens ResearchCoopervision, Inc.CompletedContact Lens Related Dry EyeCanada
-
Singapore National Eye CentreCompleted
Clinical Trials on Virtual reality game
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityCompletedHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid NeoplasmUnited States
-
Hull University Teaching Hospitals NHS TrustCompletedBrain Injuries | Cognitive DysfunctionUnited Kingdom
-
University of WashingtonCompleted
-
Selcuk UniversityCompleted
-
Kırıkkale UniversityCompletedAlzheimer's DementiaTurkey
-
Koç UniversityCompleted
-
Taipei Medical UniversityCompleted
-
University of Massachusetts, LowellSpaulding Rehabilitation Hospital; Hugo W. Moser Research Institute at Kennedy...Recruiting
-
Taipei Medical University Shuang Ho HospitalCompleted
-
Universidade Federal do Rio Grande do NorteConselho Nacional de Desenvolvimento Científico e TecnológicoUnknown